Moxatag

Pragma Pharmaceuticals Announces Re-Launch of Moxatag

Pragma Pharmaceuticals is pleased to announce that it is re-launching Moxatag775 mg (amoxicillin extended-release tablets), the only once-a-day amoxicillin.

Moxatag“Amoxicillin is the gold standard in treating strep pharyngitis. Simplifying the dosing regimen is a no brainer. Greater convenience to help patient compliance is key to ensuring effective antibiotic therapy.”

Pragma acquired Moxatag from Shionogi Inc. in March 2014 and has been working to make the product available in time for the upcoming cold and flu season.

A Pragma spokesperson talking with Health Magazine says, “Amoxicillin is the gold standard in treating strep pharyngitis. Simplifying the dosing regimen is a no brainer. Greater convenience to help patient compliance is key to ensuring effective antibiotic therapy.”

Fera Pharmaceuticals has been selected to manage the sales and marketing of Moxatag for Pragma.

Leave a Reply

Your email address will not be published. Required fields are marked *